Boston Partner Roger Lane was quoted in a July 9, 2013 Law360 article titled “Pain Now or Later? Thermo Fisher Tastes Earnout Bitters.” The article discusses how earnouts often result in infighting rather than bridging the gap between what sellers want and what buyers are willing to pay for unproven assets-something Thermo Fisher Scientific Inc. is finding out. Mr. Lane, a member of Foley’s Emerging Technologies Industry Team, was quoted saying, “Most buyers are reluctant to make guarantees about budgets or staffing levels. Often a seller’s best hope is a negative covenant, where the buyer promises not to do anything to undermine the seller’s efforts.” Mr. Lane also stated, “You can’t anticipate everything. You handicap the deal the best you can, and you live with it … especially when the alternative is that there is no deal.” But “at the end of the day, terms like that mean different things to different people, in light of circumstances that may have changed,” Mr. Lane said. “That’s most often what the litigation comes down to – interpreting the terms you spend all that time hammering out.”
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.